share_log

HC Wainwright & Co. Maintains Buy on LAVA Therapeutics, Lowers Price Target to $6

Benzinga ·  Aug 23, 2023 06:17

HC Wainwright & Co. analyst Arthur He maintains LAVA Therapeutics (NASDAQ:LVTX) with a Buy and lowers the price target from $9 to $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment